Kirin Holdings Co (KNBWY) AI Stock Analysis

• Market Cap: $11.61B
• Dividend Yield: 2.25%
• Average Volume (3M): 1.02K
• Price to Earnings (P/E): 12.4
• Beta (1Y): -0.17
• Revenue Growth: 5.64%
• EPS Growth: -22.32%
• Country: US
• Employees: 31,934
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Beverages - Alcoholic
• EPS (TTM): 0.36
• Shares Outstanding: 816,000,000
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 1,024
• PEG Ratio: 0.07
• Price to Book (P/B): 1.49
• Price to Sales (P/S): 0.75
• P/FCF Ratio: 15.23
• Enterprise Value/Market Cap: 247.57
• Enterprise Value/Revenue: 1.17
• Enterprise Value/Gross Profit: 2.46
• Enterprise Value/Ebitda: 8.60
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1.39
• Revenue Forecast (FY): $15.93B

• Rating: 72 Outperform
• Price Target: $19.00 ▲(25.16% Upside)
• Action: Upgraded Date: 02/18/26
• Date: Action: Upgraded 02/18/26

The score is driven primarily by improved 2025 financial performance (stronger growth and margin rebound) balanced against weaker cash conversion. Technicals are supportive but appear overextended (high RSI/Stoch), while valuation looks reasonable with a moderate P/E and a ~2.34% dividend yield.

Positive Factors

Revenue Momentum

Accelerating revenue to 6.1% in 2025 signals regained top-line momentum across product categories and geographies. Sustainable organic growth supports reinvestment in brands and distribution, underpins margin expansion, and reduces reliance on one-off fixes over the medium term.

Margin Recovery and Profitability

Improved gross, EBIT and net margins demonstrate restored operational leverage and pricing power. Sustained higher margins increase resilience to input-cost shocks, improve free cash flow potential long term, and create more internal capital for dividends, capex, or strategic investments.

Diversified Business Model

Kirin's multi-segment footprint across alcoholic and non-alcoholic beverages, food and pharmaceuticals diversifies revenue and risk. Structural diversification cushions against single-segment cyclicality, enables cross-selling and more stable mid-term cash flows, supporting strategic flexibility.

Negative Factors

Weak Cash Conversion

Free cash flow at ~41% of reported net income indicates a persistent profit-to-cash gap, likely from working-capital swings or heavier reinvestment. Poor conversion constrains the firm's ability to self-fund capex, M&A or steady shareholder returns if profits wobble.

Earnings Volatility

Documented earnings volatility, including a material dip in 2024, highlights sensitivity to costs, mix or one-time items. Persistent volatility undermines forecasting and capital allocation, raising the likelihood that short-term profits won’t reliably translate into long-term cash or returns.

Rising Leverage Trend

Leverage creeping higher to ~0.72 reduces financial headroom versus prior years. If margins or cash conversion weaken, the higher debt load amplifies refinancing and solvency risk, limiting strategic options and increasing downside in an economic slowdown.

Kirin Holdings Co Business Overview & Revenue Model

Company Description

Kirin Holdings Company, Limited produces and sells alcoholic beverages, soft drinks, pharmaceuticals, and other related products in Japan and internationally. It operates through four segments: Japan Beer and Spirits Businesses, Japan Non-Alcoholic Beverages Business, Oceania Integrated Beverages Business, and Pharmaceuticals Business. The company's products include beer, happo-shu, wine, whiskey, spirits, soft drinks, dairy products, fruit juices, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks, and sake and other food products; as well as manufacture and supply of Four Roses bourbon; and acts as an insurance agent. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Kirin Holdings generates revenue through multiple key streams, primarily from the sale of alcoholic beverages, including beers, wines, and spirits, which constitute a significant portion of its income. The company also earns revenue from non-alcoholic beverages, such as soft drinks and health products. Kirin's business model benefits from a strong brand presence in both domestic and international markets, with strategic partnerships and distribution agreements that enhance its market reach. The company has also invested in the food sector, providing additional revenue opportunities, while its pharmaceutical division contributes to earnings through the development and sale of health-related products. Overall, Kirin's diversified product portfolio and market strategies are crucial in driving its overall financial performance.

Kirin Holdings Co Financial Statement Overview

Summary

2025 showed a clear rebound: revenue growth accelerated to ~6.1% and profitability improved meaningfully (net margin ~6.1%, EBIT margin ~10.3%, gross margin ~47.6%). Balance sheet leverage is manageable (debt-to-equity ~0.72) but has drifted up from 2022–2023 levels, and cash conversion remains a key weakness with free cash flow only ~41% of net income in 2025.

Income Statement

Top-line momentum is solid, with revenue growth accelerating to 6.1% in 2025 versus ~0.1% in 2024 and ~7–9% in 2022–2023. Profitability improved meaningfully in 2025: net margin rebounded to ~6.1% (from ~2.5% in 2024) and operating profitability strengthened (EBIT margin ~10.3%, EBITDA margin ~14.5%), while gross margin also expanded (~47.6%). The main weakness is earnings volatility across the period (notably the 2024 dip), indicating results can swing with costs, mix, or one-time items.

Balance Sheet

Leverage looks manageable for the sector, with debt-to-equity around ~0.72 in 2025 (similar to 2024) and a clear improvement from 2020 (~0.77), though it has risen from the lower 2022–2023 levels (~0.53–0.58). Equity has grown steadily (to ~1.29T in 2025), supporting a larger asset base. Returns to shareholders improved strongly in 2025 (~12.0% return on equity) versus 2024 (~4.9%), but the upward drift in leverage since 2022 is a key risk to monitor if profitability softens.

Cash Flow

Cash generation improved in 2025 with operating cash flow rising to ~309.8B and free cash flow to ~125.6B, alongside a sharp free-cash-flow rebound versus 2024. However, cash conversion is a recurring weak point: free cash flow runs at ~41% of net income in 2025 (and ~26% in 2024), suggesting working-capital swings or heavier reinvestment needs. Overall cash flow is positive and improving, but consistency and conversion quality trail the strength seen in reported profits.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.55T	2.34T	2.13T	1.99T	1.82T
Gross Profit	1.21T	1.07T	963.47B	905.71B	822.84B
EBITDA	370.78B	253.42B	294.80B	251.27B	227.59B
Net Income	154.69B	58.21B	112.70B	111.01B	59.79B
Balance Sheet
Total Assets	3.50T	3.35T	2.87T	2.54T	2.47T
Cash, Cash Equivalents and Short-Term Investments	125.38B	127.19B	140.34B	96.44B	157.40B
Total Debt	924.06B	857.57B	656.40B	523.12B	551.47B
Total Liabilities	1.90T	1.82T	1.44T	1.29T	1.32T
Stockholders Equity	1.29T	1.18T	1.13T	980.02B	894.18B
Cash Flow
Free Cash Flow	125.65B	62.26B	89.40B	37.08B	132.97B
Operating Cash Flow	309.75B	242.84B	203.21B	135.56B	219.30B
Investing Cash Flow	-279.72B	-329.38B	-226.09B	-10.40B	-56.41B
Financing Cash Flow	-30.15B	58.13B	35.91B	-167.84B	-180.46B

Kirin Holdings Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 15.18
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KNBWY, the sentiment is Positive. The current price of 15.18 is below the 20-day moving average (MA) of 16.59, below the 50-day MA of 15.79, and above the 200-day MA of 14.80, indicating a bullish trend. The MACD of 0.39 indicates Positive momentum. The RSI at 52.88 is Neutral, neither overbought nor oversold. The STOCH value of 47.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KNBWY.

Kirin Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ABEV	80 Outperform	$45.77B	13.63	17.42%	8.22%	-0.68%	4.29%
KNBWY	72 Outperform	$11.61B	12.37	6.93%	2.25%	5.64%	-22.32%
FMX	70 Outperform	$21.92B	35.36	6.75%	4.33%	1.44%	-38.87%
BUD	68 Neutral	$147.51B	18.53	8.29%	1.83%	-2.06%	21.03%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
TAP	54 Neutral	$9.34B	-4.26	-18.35%	4.08%	-4.01%	-339.22%
CCU	53 Neutral	$2.25B	19.13	9.07%	2.53%	16.59%	1.72%